Intra-Cellular Therapies
ITCI
#1310
Rank
ยฃ10.75 B
Marketcap
ยฃ101.12
Share price
0.00%
Change (1 day)
96.87%
Change (1 year)

Revenue for Intra-Cellular Therapies (ITCI)

Revenue in 2024 (TTM): ยฃ0.53 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM ) is ยฃ0.52 Billion. an increase over the revenue in the year 2023 that were of ยฃ0.36 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intra-Cellular Therapies from 2014 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ0.54 B49.48%
2023 ยฃ0.36 B76.17%
2022 ยฃ0.20 B240.2%
2021 ยฃ60.53 M266.21%
2020 ยฃ16.52 M35659.89%
2019 ยฃ0.04 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 ยฃ0.02 M-94.12%
2014 ยฃ0.35 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.89 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ98.24 M-81.23%๐Ÿ‡บ๐Ÿ‡ธ USA